| |
| |
|
| Insider
Information: |
Ramsay David A |
| Relationship: |
Director |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,587,962 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,036,962 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,587,962 |
|
|
| Total
Value |
$25,036,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
0
|
|
Stock
price went up :
|
46
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.8
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
VP and Chief Financial... |
2015-02-06 |
364,320 |
|
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
2,223,642 |
2012-05-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVRA |
Savara Inc |
Director |
– • – |
2021-03-15 |
4 |
B |
$1.45 |
$1,000,000 |
D/D |
689,655 |
811,797 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2013-09-16 |
4 |
OE |
$0.39 |
$50,700 |
D/D |
130,000 |
236,735 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Vice President and CFO |
• – – |
2005-01-14 |
4 |
OE |
$0.39 |
$39,000 |
D/D |
100,000 |
376,410 |
|
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2022-08-22 |
4 |
D |
$6.23 |
$623,000 |
D/D |
(100,000) |
0 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-27 |
4 |
B |
$1.37 |
$101,381 |
D/D |
73,893 |
1,876,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-08-17 |
4 |
B |
$1.18 |
$78,201 |
D/D |
66,554 |
933,354 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2012-05-14 |
4 |
B |
$0.54 |
$26,965 |
D/D |
50,000 |
100,000 |
2.39 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-09-16 |
4 |
OE |
$2.05 |
$102,500 |
D/D |
50,000 |
298,492 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-05-18 |
4 |
B |
$1.62 |
$81,100 |
D/D |
50,000 |
861,797 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-09-30 |
4 |
B |
$1.30 |
$64,900 |
D/D |
50,000 |
1,101,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-05-24 |
4 |
B |
$2.56 |
$127,800 |
D/D |
50,000 |
2,151,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-09-29 |
4 |
B |
$1.28 |
$60,658 |
D/D |
47,500 |
1,051,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-22 |
4 |
B |
$1.48 |
$61,127 |
D/D |
41,414 |
2,046,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-19 |
4 |
B |
$1.49 |
$60,834 |
D/D |
40,719 |
1,987,312 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2012-05-10 |
4 |
B |
$0.57 |
$22,612 |
D/D |
40,000 |
50,000 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-06-17 |
4 |
B |
$1.33 |
$52,915 |
D/D |
39,906 |
1,541,048 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-01 |
4 |
B |
$1.42 |
$56,471 |
D/D |
39,768 |
1,701,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-09-28 |
4 |
B |
$1.29 |
$50,824 |
D/D |
39,552 |
1,003,642 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-08-31 |
4 |
B |
$1.42 |
$56,200 |
D/D |
39,494 |
1,661,374 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-06-22 |
4 |
B |
$1.45 |
$56,355 |
D/D |
39,000 |
1,601,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2023-05-26 |
4 |
B |
$2.63 |
$97,599 |
D/D |
37,124 |
2,201,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-28 |
4 |
B |
$2.33 |
$82,309 |
D/D |
35,157 |
122,142 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-10 |
4 |
B |
$1.04 |
$36,365 |
D/D |
35,000 |
1,411,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-30 |
4 |
B |
$1.30 |
$45,360 |
D/D |
35,000 |
1,501,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-26 |
4 |
B |
$1.38 |
$43,052 |
D/D |
31,107 |
1,802,249 |
2.39 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
